T

he European Union’s antitrust watchdog is investigating Merck KGgA — the German company — for providing “incorrect or misleading information” about its $17 billion acquisition of Sigma-Aldrich, which was a U.S. supplier of laboratory testing materials.

The European Commission had approved the deal in June 2015, but only on the condition that the companies agreed to sell certain portions of their lab chemicals business over concerns the merger would reduce competition.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.